Tango Therapeutics (TNGX) Non-cash Items (2020 - 2026)

Tango Therapeutics' Non-cash Items history runs 7 years deep, the most recent figure standing at $12.2 million for Q1 2026.

• In Q1 2026, Non-cash Items fell 6.0% year-over-year to $12.2 million; the TTM figure through Mar 2026 stood at $12.2 million (down 6.0% YoY), while the FY2025 annual figure was $60.7 million, up 2714.84% from the prior year.
• Non-cash Items was $12.2 million for Q1 2026 at Tango Therapeutics, down from $60.7 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $27.1 billion in Q1 2022 to a low of $2.2 million in Q4 2024.
• Historically, Non-cash Items has averaged $3.8 billion across 5 years, with a median of $20.8 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Non-cash Items sank 99.99% in 2022, then soared 2714.84% in 2025.
• A 5-year view of Non-cash Items shows it stood at $24.3 billion in 2022, then tumbled by 99.74% to $62.6 million in 2023, then tumbled by 96.56% to $2.2 million in 2024, then jumped by 2714.84% to $60.7 million in 2025, then plunged by 79.98% to $12.2 million in 2026.
• The last three Non-cash Items figures came in at $12.2 million (Q1 2026), $60.7 million (Q4 2025), and $59.8 million (Q3 2025), per Business Quant data.